Stage 3 melanoma was the first cancer area to have an FDA-approved immunotherapy to prevent disease from returning after surgery.
Conferences
ESMO announces award winners
The European Society for Medical Oncology announced the recipients of this year’s ESMO Awards.
For cancer treatment and more, genetic-based precision medicine holds a lot of promise
A month following surgery for thyroid cancer, a Hartford Hospital patient’s tumor grew to 10 inches. The case was presented to the hospital’s tumor board, which involved 30 doctors from different specialties.
A new approach to predict the evolutionary mechanisms of melanoma
Melanoma is a malignant tumour resulting from the transformation of melanocytes, the cells in the skin that undertake to synthesise melanin, a complex polymer which protects us from the negative effects of solar radiation.